Follicular meiosis-activating sterolAlternative Names: FF-MAS
Latest Information Update: 16 Jul 2016
At a glance
- Originator Nonindustrial source; Novo Nordisk; Rigshospitalet
- Developer Nonindustrial source; Novo Nordisk
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Female infertility
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Female-infertility in Denmark
- 24 Mar 2000 New profile
- 24 Mar 2000 Preclinical development for Female infertility in Denmark (Unknown route)